Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample

Abstract Cognitive impairment occurs at higher rates in individuals at clinical high risk (CHR) for psychosis relative to healthy peers, and it contributes unique variance to multivariate prediction models of transition to psychosis. Such impairment is considered a core biomarker of schizophrenia. T...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kelly Allott, Walid Yassin, Luis Alameda, Tashrif Billah, Owen Borders, Kate Buccilli, Ricardo E. Carrión, Rolando I. Castillo-Passi, Kang Ik K. Cho, Kota Chin, Michael J. Coleman, Beau-Luke Colton, Sebastián Corral, Dominic Dwyer, Kristina Ballestad Gundersen, Ruben C. Gur, Gil D. Hoftman, Grace R. Jacobs, Sinead Kelly, Kathryn E. Lewandowski, Patricia J. Marcy, Priya Matneja, Danielle McLaughlin, Angela R. Nunez, Setari Parsa, Nora Penzel, Susan Ray, Jenna M. Reinen, Kosha Ruparel, Michael S. Sand, Gennarina Santorelli, Johanna Seitz-Holland, Jessica Spark, Zailyn Tamayo, Andrew Thompson, Sophie Tod, Cassandra M. J. Wannan, Alana Wickham, Stephen J. Wood, Eirini Zoupou, Jean Addington, Alan Anticevic, Celso Arango, Nicholas J. K. Breitborde, Matthew R. Broome, Kristin S. Cadenhead, Monica E. Calkins, Eric Yu Hai Chen, Jimmy Choi, Philippe Conus, Cheryl M. Corcoran, Barbara A. Cornblatt, Lauren M. Ellman, Paolo Fusar-Poli, Pablo A. Gaspar, Carla Gerber, Louise Birkedal Glenthøj, Leslie E. Horton, Christy Lai Ming Hui, Joseph Kambeitz, Lana Kambeitz-Ilankovic, Matcheri Keshavan, Sung-Wan Kim, Nikolaos Koutsouleris, Jun Soo Kwon, Kerstin Langbein, Daniel Mamah, Covadonga M. Diaz-Caneja, Daniel H. Mathalon, Vijay A. Mittal, Merete Nordentoft, Godfrey D. Pearlson, Diana O. Perkins, Jesus Perez, Albert R. Powers, Jack Rogers, Fred W. Sabb, Jason Schiffman, Jai L. Shah, Steven M. Silverstein, Stefan Smesny, Gregory P. Strauss, Judy L. Thompson, Rachel Upthegrove, Swapna K. Verma, Jijun Wang, Daniel H. Wolf, Ofer Pasternak, Sylvain Bouix, Patrick D. McGorry, John M. Kane, Rene S. Kahn, Carrie E. Bearden, Martha E. Shenton, Scott W. Woods, Barnaby Nelson, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), William S. Stone
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2025-03-01
coleção:	Schizophrenia
Acesso em linha:	https://doi.org/10.1038/s41537-025-00578-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!